The use of smart watch technology to improve the management of patients presenting with fast irregular heart rates in the Emergency department - a pilot study
- Conditions
- Atrial FibrillationCardiovascular - Other cardiovascular diseasesEmergency medicine - Other emergency care
- Registration Number
- ACTRN12620001374954
- Lead Sponsor
- Eastern Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 50
50 patients with AF onset less than 24 hours presenting to ED who are able to have delayed cardioversion.
•Age: 18 years or greater
•Residing within the Eastern Health catchment during the initial intervention period (48 hours from time of ED presentation)
•Haemodynamically stable
•Recent onset AF : <24 hours of symptomatic first episode or recurrent AF
•Have compatible smart phone or tablet to use the Alivecor device
•AF onset time unclear.
•History of long-standing persistent AF (continuous AF for more than 1 year)
•Patients with haemodynamically unstable AF who require emergent cardioversion
•Have a cardiac pacemaker or implantable cardioverter defribrillator or other implanted electronic device
•Unable to provide informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total number of emergency department time spent per visit for enrolled participants compared with historical age matched controls. [Four weeks after initial presentation to hospital with AF as assessed by hospital records.]
- Secondary Outcome Measures
Name Time Method Results of readings during remote monitoring period and need for repeat ED review. Results of readings are classified as follows:<br>oReversion to sinus rhythm. ED review not required<br>oPossible AF, requiring ED review<br>oUninterpretable, requiring ED review<br>oUnclassified, requiring ED review<br>The ECG's will be reviewed manually by the study physician.<br>[First 48 hours];Proportion of participants subsequently requiring ED cardioversion as assessed by hospital records.[First 4 weeks];Presence of AF at 4-week cardiology outpatient review, assessed as the presence of AF on ECG.[First 4 weeks ]